Stryker (SYK) Cash from Operations Growth (5y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.15% |
| Dec 31, 2025 | 11.62% |
| Sep 30, 2025 | 13.19% |
| Jun 30, 2025 | 12.37% |
| Mar 31, 2025 | -15.81% |
| Dec 31, 2024 | 21.31% |
| Sep 30, 2024 | 18.57% |
| Jun 30, 2024 | 4.25% |
| Mar 31, 2024 | -8.21% |
| Dec 31, 2023 | 7.87% |
| Sep 30, 2023 | 11.18% |
| Jun 30, 2023 | 1.17% |
| Mar 31, 2023 | 8.42% |
| Dec 31, 2022 | 8.12% |
| Sep 30, 2022 | 62.28% |
| Jun 30, 2022 | -4.04% |
| Mar 31, 2022 | 6.10% |
| Dec 31, 2021 | 8.73% |
| Sep 30, 2021 | 13.20% |
| Jun 30, 2021 | 12.24% |
| Mar 31, 2021 | 11.52% |
| Dec 31, 2020 | 10.44% |
| Sep 30, 2020 | 29.40% |
| Jun 30, 2020 | 11.67% |
| Mar 31, 2020 | 9.23% |
| Dec 31, 2019 | 1.60% |
| Sep 30, 2019 | 3.29% |
| Jun 30, 2019 | 7.03% |
| Mar 31, 2019 | 8.41% |
| Dec 31, 2018 | 9.25% |
| Sep 30, 2018 | -0.13% |
| Jun 30, 2018 | 12.76% |
| Mar 31, 2018 | 4.71% |
| Dec 31, 2017 | 2.64% |
| Sep 30, 2017 | -32.62% |
| Jun 30, 2017 | 7.30% |
| Mar 31, 2017 | 33.96% |
| Dec 31, 2016 | 0.97% |
| Sep 30, 2016 | 2.39% |
| Jun 30, 2016 | 25.72% |
| Mar 31, 2016 | 5.13% |
| Dec 31, 2015 | 7.81% |
| Sep 30, 2015 | -26.11% |
| Jun 30, 2015 | 1.79% |
| Mar 31, 2015 | 6.70% |
| Dec 31, 2014 | 4.67% |
| Sep 30, 2014 | 2.81% |
| Jun 30, 2014 | 14.95% |
| Mar 31, 2014 | -5.16% |